Amniotic membrane in ophthalmology: indications and limitations

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Biomaterials

Background:

• Amniotic membrane is utilized for ocular surface disorders.
• Clinical success in case reports lacks robust randomized controlled trial (RCT) substantiation.
• Current evidence suggests comparable or inferior efficacy to alternatives, potentially at higher costs.

Purpose of the Study:

• To critically evaluate the efficacy and safety of amniotic membrane in ophthalmic treatments.
• To identify factors contributing to variable outcomes with amniotic membrane grafts.
• To explore the potential of standardized synthetic membranes as alternatives.

Main Methods:

• Review of published randomized controlled trials (RCTs) and case series on amniotic membrane use in ophthalmology.
• Analysis of factors influencing amniotic membrane efficacy, including donor variability and processing.
• Discussion of safety concerns, particularly infectious disease transmission risks.
• Consideration of synthetic biomaterial development for ocular surface repair.

Main Results:

• Few RCTs do not consistently support the efficacy of amniotic membrane for ocular surface conditions.
• Outcomes are variable, potentially due to donor-to-donor variations and processing.
• Significant safety concerns exist regarding infectious disease transmission from non-standardized membranes.
• The exact mechanism of action remains unclear, presumed to be a scaffold for cellular repair.

Conclusions:

• Amniotic membrane's clinical utility for ocular surface conditions is not definitively proven by high-level evidence.
• Product variability and safety risks necessitate caution and highlight the need for standardization.
• Development of standardized synthetic membranes offers a promising direction for consistent and safe ocular surface regeneration.